ANT-GROUP
13.6.2024 06:45:32 CEST | Business Wire | Press release
Ant Group (or “the Company”) today released its 2023 Sustainability Report, showcasing the Company’s significant progress since the introduction of its ESG strategy in 2022 and demonstrating its commitment to transparency and to its sustainable business practices.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240612743798/en/
Technological Innovation (Graphic: Business Wire)
The report highlights noteworthy advancements across key areas, underpinned by four core pillars: Technological Innovation, Digital Inclusion, Green and Low-Carbon Development, and Open Ecosystem.
“Looking ahead, we are constantly reflecting on how to stay true to our original aspirations in this era of rapid change, continuously bringing about more small yet beautiful changes to the world,” said Eric Jing, Chairman & CEO of Ant Group. “Since our journey started from Alipay’s inception in 2004, technology-driven innovation has always been the fundamental force propelling our growth. It will play an even greater role in shaping our future.”
Technological Innovation
To drive innovation for consumers, small and micro-sized enterprises (SMEs) and partners, Ant Group has increased its investment in technology R&D for three consecutive years, reaching a record high of RMB 21.19 billion yuan (~ 2.92 billion USD) in 2023. Ant Group’s BaiLing Foundation Model, which was approved to serve the Chinese public in 2023, has been powering AI assistants that make it easier for users to access various life services on the Alipay platform, from smart life assistant, to smart healthcare manager and smart financial manager.
Digital Inclusion
By leveraging digital payment and finance innovation, Ant Group, together with its associate MYbank, have served more than 87 million SMEs as of 2023.
On the Alipay platform, thousands of Independent Software Vendors (ISVs) have developed more than 700 digital solutions for 4.27 million merchants, enabling them to seize more business opportunities through digital operations. In 2023, the annual transaction volume of merchant operated Alipay mini-programs grew by 68% year-on-year.
Green and Low-Carbon Development
By the end of 2023, Ant Group had achieved operation-wide carbon neutrality for three consecutive years, with a 43.19% reduction in absolute Scope 1 & 2 emissions compared to the 2020 baseline year. In accordance with standards such as the "Greenhouse Gas Protocol: Corporate Value Chain (Scope 3) Accounting and Reporting Standards" and the "Global Financial Industry Greenhouse Gas Accounting and Reporting Standards," Ant Group conducted the Company’s first comprehensive accounting for Scope 3 carbon emissions in 2023, covering 11 categories related to activities along Ant Group's value chain, which provides a scientific basis for further emission reduction initiatives.
Since its launch in 2016, Alipay Ant Forest has encouraged more than 690 million users to make everyday low-carbon choices. As a result, 475 million trees have been planted by local partners with financial support from the Company.
Open Ecosystem
To better connect travelers with merchants and facilitate cross-border commerce, more than 25 leading e-wallets and banking apps have adopted Alipay+, a suite of cross-border digital payment and digitalization technology solutions. Alipay+ enables their users to pay and travel like locals, bringing international businesses to over 88 million merchants worldwide. In addition, with its one World Account, WorldFirst has served one million SME traders to pay, connect, and manage money globally.
The 10x1000 Tech for Inclusion program has provided exchange and learning opportunities for 6,243 certified learners from over 100 countries and regions, of whom nearly half are women participants.
Ant Group, after establishing 19 sustainability issues with 3-year OKRs (Objectives and Key Results) and plans in 2022, has upgraded its governance and incentive system in line with global best practices. This includes linking senior management’s remuneration to the Company’s risk management and sustainability performance metrics.
In 2023, Ant Group used relevant Sustainability Accounting Standards Board(SASB) industry standards as a guiding reference for its sustainability reporting for the first time. Ant Group also bolstered its climate-related disclosures with reference to the International Sustainability Standards Board (ISSB) requirements, including detailing how its executives and senior management tackle climate-related decisions as well as the establishment of an early warning platform to monitor extreme weather's impact on business operations.
Note: All figures are as of December 31, 2023 unless otherwise specified. The 2023 Sustainability Report is available in Chinese. The English-language version will be available on Ant Group’s official website soon.
About Ant Group
Ant Group aims to build the infrastructure and platforms to support the digital transformation of the service industry. Through continuous innovation, we strive to provide all consumers and small and micro businesses equal access to digital financial and other daily life services that are convenient, sustainable and inclusive.
For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240612743798/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom